SEP
INSM icon

Signature Equity Partners’s Insmed INSM Stock Holding History

Signature Equity Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.63K Sell
34
-9
-21% -$1.09K ﹤0.01% 1053
2026
Q1 		$7.03K Buy
43
+21
+95% +$3.23K ﹤0.01% 890
2025
Q4 		$3.83K Buy
+22
New +$4.01K ﹤0.01% 1065

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Signature Equity Partners's INSM Position: Q2 2026 in Review

Signature Equity Partners reduced its Insmed (INSM) stake by 21% in Q2 2026, selling an estimated $1.09K and leaving 34 shares worth $3.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Signature Equity Partners first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.03K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Signature Equity Partners held 34 shares of Insmed worth $3.63K as of Q2 2026.
  • Signature Equity Partners sold 9 Insmed shares in Q2 2026, an estimated $1.09K.
  • Insmed made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1053 holding.
  • Signature Equity Partners first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Insmed position peaked at $7.03K in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.